Earnings due out tomorrow along with conference call afterhours.
They must get bid to 1.00 to stay trading on the current exchange. Easy money here.
Company has cash on hand. There are several reasons why this is a buy. I would encourage players to take a look into it.
I personally have been buying for a few weeks now awaiting a bounce.
Should be interesting to see what they say in the conference call. Hopefully future plans and updates on the drug approval for the United States, which is already approved in other states.